These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

123 related items for PubMed ID: 2274676

  • 21. Biological effects of a proglumide derivative as cholecystokinin antagonist in conscious dogs.
    Hildebrand P, Beglinger C, Köhler E, Setnikar I, Gyr K.
    Regul Pept; 1987 Aug 17; 18(3-4):213-20. PubMed ID: 3446223
    [Abstract] [Full Text] [Related]

  • 22. Cholecystokinin in the regulation of gastric acid and endocrine pancreatic secretion in humans.
    Konturek JW, Stoll R, Gutwinska-Konturek M, Konturek SJ, Domschke W.
    Scand J Gastroenterol; 1993 May 17; 28(5):401-7. PubMed ID: 8511500
    [Abstract] [Full Text] [Related]

  • 23. Effects of cholecystokinin-receptor blockade on pancreatic and biliary function in healthy volunteers.
    Schwarzendrube J, Niederau M, Lüthen R, Niederau C.
    Gastroenterology; 1991 Jun 17; 100(6):1683-90. PubMed ID: 2019374
    [Abstract] [Full Text] [Related]

  • 24.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 25.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 26. Differential effects of atropine and a cholecystokinin receptor antagonist on pancreatic secretion.
    Adler G, Reinshagen M, Koop I, Göke B, Schafmayer A, Rovati LC, Arnold R.
    Gastroenterology; 1989 Apr 17; 96(4):1158-64. PubMed ID: 2647576
    [Abstract] [Full Text] [Related]

  • 27.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 28. Effect of a low dose of intraduodenal fat on satiety in humans: studies using the type A cholecystokinin receptor antagonist loxiglumide.
    Lieverse RJ, Jansen JB, Masclee AA, Rovati LC, Lamers CB.
    Gut; 1994 Apr 17; 35(4):501-5. PubMed ID: 8174988
    [Abstract] [Full Text] [Related]

  • 29. Postprandial control of gallbladder contraction and exocrine pancreatic secretion in man.
    Beglinger C, Hildebrand P, Adler G, Werth B, Luo H, Delco F, Gyr K.
    Eur J Clin Invest; 1992 Dec 17; 22(12):827-34. PubMed ID: 1282465
    [Abstract] [Full Text] [Related]

  • 30.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 31. The role of cholecystokinin and the cholinergic system in intravenous amino acid-induced gallbladder emptying.
    Gielkens HA, de Boer SY, Lam WF, Rovati LC, Lamers CB, Masclee AA.
    Eur J Gastroenterol Hepatol; 1997 Dec 17; 9(12):1227-31. PubMed ID: 9471030
    [Abstract] [Full Text] [Related]

  • 32. Loxiglumide. A new proglumide analog with potent cholecystokinin antagonistic activity in the rat pancreas.
    Otsuki M, Fujii M, Nakamura T, Okabayashi Y, Tani S, Fujisawa T, Koide M, Baba S.
    Dig Dis Sci; 1989 Jun 17; 34(6):857-64. PubMed ID: 2470557
    [Abstract] [Full Text] [Related]

  • 33. Cholecystokinin in the hormonal stimulation of amino acid uptake and pancreatic enzyme secretion.
    Konturek JW, Gabryelewicz A, Stoll R, Domschke W.
    Ann N Y Acad Sci; 1994 Mar 23; 713():454-6. PubMed ID: 7514376
    [No Abstract] [Full Text] [Related]

  • 34. Cholecystokinin in the control of gastric acid secretion in man.
    Konturek JW, Stoll R, Konturek SJ, Domschke W.
    Gut; 1993 Mar 23; 34(3):321-8. PubMed ID: 8472978
    [Abstract] [Full Text] [Related]

  • 35. Physiological role of cholecystokinin on postprandial insulin secretion and gastric meal emptying in man. Studies with the cholecystokinin receptor antagonist loxiglumide.
    Fried M, Schwizer W, Beglinger C, Keller U, Jansen JB, Lamers CB.
    Diabetologia; 1991 Oct 23; 34(10):721-6. PubMed ID: 1959704
    [Abstract] [Full Text] [Related]

  • 36.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 37. Cholecystokinin in the control of gastric acid secretion in humans.
    Konturek JW, Gutwinska-Konturek M, Gabryelewicz A, Konturek SJ, Domschke W.
    J Clin Gastroenterol; 1993 Oct 23; 17 Suppl 1():S40-5. PubMed ID: 7904286
    [Abstract] [Full Text] [Related]

  • 38. Effect of loxiglumide and atropine on erythromycin-induced reduction in gallbladder volume in human subjects.
    Jebbink MC, Masclee AA, van der Kleij FG, Schipper J, Rovati LC, Jansen JB, Lamers CB.
    Hepatology; 1992 Oct 23; 16(4):937-42. PubMed ID: 1398500
    [Abstract] [Full Text] [Related]

  • 39.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 40. Effect of cholestyramine and cholecystokinin receptor antagonist CR1505 (loxiglumide) on lower esophageal sphincter pressure in man.
    Masclee AA, Jansen JB, Rovati LC, Lamers CB.
    Dig Dis Sci; 1993 Oct 23; 38(10):1889-92. PubMed ID: 8404410
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 7.